CGC Stock News & Catalysts – Canopy Growth

FEATURED

Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis

Net revenue growth of 30% in Cannabis segment 18% growth in Canada medical cannabis revenue and 17% growth in Canada adult-use cannabis revenue Company strengthens end-to-end EU GMP supply chain to facilitate

Summary

Nov 6, 2026, 7:00 AM ·Business Wire

RECENT

Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders

Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced

Oct 26, 2026, 7:30 AM ·Business Wire

Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026

Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, will release

Oct 22, 2026, 7:00 AM ·Business Wire

Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower

Certification strengthens Canopy Growth’s European growth strategy and expands its integrated EU GMP supply chainCanopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company")

Oct 13, 2026, 7:30 AM ·Business Wire

Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany

Mr. Blöte’s appointment strengthens Canopy Growth’s commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we"

Sep 28, 2026, 7:30 AM ·Business Wire

Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum

Annual General and Special Meeting of Shareholders of Canopy Growth to reconvene on Friday, October 23, 2026, at 1:00 p.m. ET Shareholders now have until Friday, October 23, 2026, at 9:00 a.m. ET to submit their

Sep 25, 2026, 2:00 PM ·Business Wire

Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting

Shareholders now have until Friday, September 25, 2026, at 12:00 p.m. ET to submit their votes Shareholders who need assistance can contact Sodali & Co. at 1-833-830-8205 toll free in North America, or

Sep 23, 2026, 7:30 AM ·Business Wire

Canopy Growth Expands European Medical Cannabis Supply Into the UK

Four Canadian-grown flower strains to be supplied for distribution in the UK medical cannabis market under Spectrum Therapeutics Canopy Growth Corporation ("Canopy Growth", "our", "we" or the

Sep 22, 2026, 7:30 AM ·Business Wire

Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline

Shareholders are encouraged to vote now ahead of the Company’s Annual General and Special Meeting of shareholders on September 25, 2026 Votes must be submitted by 1:00pm ET on September 23, 2026, to ensure they are

Sep 14, 2026, 7:30 AM ·Business Wire

Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations

New pastille and all-in-one vape formats, expanded oil and softgel offerings, and new flower SKUs build on international growth momentum Canopy Growth Corporation ("Canopy Growth", "our", "we"

Sep 8, 2026, 7:30 AM ·Business Wire

Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now

Shareholders are encouraged to vote well in advance of the meeting scheduled on September 25, 2026, at 1:00 PM ET. To ensure that votes are counted, Shareholders must submit their vote no later than 1:00 p.m. ET on

Aug 17, 2026, 7:30 AM ·Business Wire

Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows

Renewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chain Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED)

Aug 14, 2026, 7:30 AM ·Business Wire

Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses

Net revenue growth of 22% in Canada medical cannabis, 10% in Canada adult-use cannabis, 10% in international markets cannabis and 6% in Storz & Bickel Adjusted gross margin1 improves to 31% in Q1 FY2027 from 25%

Aug 7, 2026, 7:00 AM ·Business Wire

Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) will release its financial results for the first quarter fiscal year 2027 ended June 30, 2026 before financial

Jul 24, 2026, 7:30 AM ·Business Wire

Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced it will be participating at the Canaccord Genuity Growth Conference in August 2026. Canopy Growth CEO Luc

Jul 21, 2026, 7:30 AM ·Business Wire

Canopy Growth Corporation CGC · News